羊膜の市場規模、シェア、動向分析レポート：最終用途別、製品別、用途別、地域別、セグメント別予測、2024年～2030年

羊膜市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の羊膜市場規模は2024年から2030年にかけて13.1％のCAGRを記録し、2030年には85億米ドルに達すると予測されています。

世界の外傷や火傷の症例数の増加、手術の増加、羊膜ベースの製品が提供する様々な利点に関する認知度の向上は、羊膜の需要を増加させる要因となっています。羊膜には痛みを和らげる特性があるため、外科的創傷や眼科でのこれらの組織ベースの製品の採用が増加する可能性があります。

また、幹細胞や再生医療分野における研究開発費の増加や、手術件数の増加も、市場成長を増大させると予想される主な要因の一つです。世界市場は、眼科、皮膚、脳、頭頸部、泌尿生殖器、その他の外科手術など、幅広い製品への応用により、潜在的な可能性を獲得すると期待されています。加えて、羊膜移植が世界中で増加していることも、市場全体の成長に拍車をかけると予測されています。さらに、医療従事者だけでなく、個人の間でも製品の利点に関する認識が高まっていることが、予測数年間の需要を押し上げると推定されます。

しかし、熟練した専門家の不足が市場成長の妨げになると予測されています。羊膜ベースの製品は、静脈性潰瘍、褥瘡、糖尿病性足潰瘍、眼科、手術、慢性創傷の管理など、様々な分野の治療に最も一般的に使用されています。さらに、幹細胞研究や再生医療の分野での研究の増加に伴い、様々な研究機関や学術機関が、他の用途へのこれらの製品の使用を促進するための研究に従事しています。

羊膜市場レポートのハイライト

• 凍結保存羊膜セグメントは、2023年に50.0%以上の最大の収益シェアを占めました。
• 外科的創傷分野は、外科的処置の量の増加と外科的用途での幅広い製品使用により、2023年に36.7%の最大収益シェアを占めました。
• 世界的に美容整形手術や再建手術が増加していることから、2030年までに専門クリニックが最も高い市場シェアを獲得すると予測されています。
• 北米は、多数の大手企業が存在し、慢性疾患や感染症の罹患率が高いことから、2023年の売上高シェアは31.7%で市場を独占しました。
• アジア太平洋地域は、人口の多さと慢性疾患や火傷の増加により、予測期間中に14.5%のCAGRで急成長すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 羊膜市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場 促進要因分析
  • 市場抑制要因分析
• 羊膜市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 羊膜市場：製品別推定・動向分析

• セグメントダッシュボード
• 羊膜市場：製品別変動分析
• 羊膜市場：製品別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 凍結保存された羊膜
• 脱水した羊膜

第5章 羊膜市場：用途別推定・動向分析

• セグメントダッシュボード
• 羊膜市場：用途別変動分析
• 羊膜市場の用途別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 手術創
• 眼科
• その他

第6章 羊膜市場：最終用途別推定・動向分析

• セグメントダッシュボード
• 羊膜市場：最終用途別変動分析
• 羊膜市場の最終用途別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 病院
• 外来手術センター
• 専門クリニック
• 研究機関および学術機関

第7章 羊膜市場：地域別推定・動向分析

• 地域ダッシュボード
• 地域別羊膜市場変動分析
• 羊膜市場：製品、用途、最終用途別の地域推定・動向分析
• 2018年から2030年までの市場規模と予測および動向分析
• 北米
  • 北米羊膜市場推計・予測、2018年-2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州の羊膜市場推計・予測、2018年-2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • アジア太平洋地域の羊膜市場推計・予測、2018年-2030年
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ラテンアメリカの羊膜市場推計・予測、2018年-2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東およびアフリカの羊膜市場推計・予測、2018年-2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 市場参入企業の分類
• 主要企業プロファイル
  • Alliqua BioMedical Inc.
  • Amnio Technology, LLC.
  • Applied Biologics LLC
  • Human Regenerative Technologies, LLC
  • DermaSciences
  • Katena Products, Inc.
  • MiMedx Group Inc.
  • Skye Biologics, Inc.
  • Amniox Medical Inc.
  • Integra LifeSciences

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 4 Global amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 5 Global amniotic membrane market, by end use (USD Million) 2018 - 2030
• Table 6 North America amniotic membrane market, by region, 2018 - 2030 (USD Million)
• Table 7 North America amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 8 North America amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 9 North America amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 10 U.S. amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 11 U.S. amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 12 U.S. amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 13 Canada amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 14 Canada amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 15 Canada amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 16 Mexico amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 17 Mexico amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 18 Mexico amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 19 Europe amniotic membrane market, by country, 2018 - 2030 (USD Million)
• Table 20 Europe amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 21 Europe amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 22 Europe amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 23 UK amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 24 UK amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 25 UK amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 26 Germany amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 27 Germany amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 28 Germany amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 29 France amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 30 France amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 31 France amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 32 Italy amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 33 Italy amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 34 Italy amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 35 Spain amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 36 Spain amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 37 Spain amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 38 Norway amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 39 Norway amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 40 Norway amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 41 Sweden amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 42 Sweden amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 43 Sweden amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 44 Denmark amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 45 Denmark amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 46 Denmark amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific amniotic membrane market, by country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 51 Japan amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 52 Japan amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 53 Japan amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 54 China amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 55 China amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 56 China amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 57 India amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 58 India amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 59 India amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 60 Australia amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 61 Australia amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 62 Australia amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 63 South Korea amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 64 South Korea amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 65 South Korea amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 66 Thailand amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 67 Thailand amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 68 Thailand amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 69 Latin America amniotic membrane market, by country, 2018 - 2030 (USD Million)
• Table 70 Latin America amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 71 Latin America amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 72 Latin America amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 73 Brazil amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 74 Brazil amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 75 Brazil amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 76 Argentina amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 77 Argentina amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 78 Argentina amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa amniotic membrane market, by country, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 83 South Africa amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 84 South Africa amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 85 South Africa amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 89 UAE amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 90 UAE amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 91 UAE amniotic membrane market, by end use, 2018 - 2030 (USD Million)
• Table 92 Kuwait amniotic membrane market, by product, 2018 - 2030 (USD Million)
• Table 93 Kuwait amniotic membrane market, by application, 2018 - 2030 (USD Million)
• Table 94 Kuwait amniotic membrane market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Amniotic membrane market segmentation
• Fig. 7 Market driver analysis (Current & future impact)
• Fig. 8 Market restraint analysis (Current & future impact)
• Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 10 Porter's Five Forces Analysis
• Fig. 11 Amniotic membrane market, product outlook key takeaways (USD Million)
• Fig. 12 Amniotic membrane market: product movement analysis (USD Million), 2023 & 2030
• Fig. 13 Cryopreserved amniotic membrane market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 14 Dehydrated amniotic membrane market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 15 Amniotic Membrane market, application outlook key takeaways (USD Million)
• Fig. 16 Amniotic Membrane market: application movement analysis (USD Million), 2023 & 2030
• Fig. 17 Surgical wounds market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 18 Ophthalmology market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Amniotic Membrane market, end use outlook key takeaways (USD Million)
• Fig. 21 Amniotic Membrane market: end use movement analysis (USD Million), 2023 & 2030
• Fig. 22 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Ambulatory surgical centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Specialty clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Research institutes and academic institutes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Amniotic Membrane market: Regional key takeaways (USD Million)
• Fig. 27 Amniotic Membrane market: regional outlook, 2023 & 2030, USD Million
• Fig. 28 North America amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 U.S. amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Canada amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Mexico amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Europe amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 UK amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Germany amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 France amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Spain amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Italy amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Sweden amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Norway amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Denmark amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Asia Pacific amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 China amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Japan amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 India amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 South Korea amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Australia amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Thailand amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Latin America amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Brazil amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Argentina amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Middle East and Africa amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 South Africa amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Saudi Arabia amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 UAE amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Kuwait amniotic membrane market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 List of key emerging company's/technology disruptors/innovators

Amniotic Membrane Market Growth & Trends:

The global amniotic membrane market size is expected to reach USD 8.50 billion by 2030, registering a CAGR of 13.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Global rise in the number of trauma and burn cases, surgeries, and increasing cognizance regarding various benefits offered by amniotic membrane-based products are factors increasing their demand. Amniotic membrane has pain-reducing properties, which may lead to the increased adoption of these tissue-based products in surgical wounds and ophthalmology.

Also, rising expenditure in R&D in the field of stem cells and regenerative medicine and the rising number of surgeries being performed are some of the key factors anticipated to augment the market growth. The global market is expected to gain potential owing to a wide range of product applications in ophthalmology, skin, brain, and head & neck, genitourinary tract, as well as other surgical procedures. In addition, the rise in amniotic membrane-based transplantations across the globe is predicted to fuel the overall market growth. Moreover, rising awareness regarding the product benefits among healthcare professionals as well as individuals is estimated to boost the demand over the forecast years.

However, the dearth of skilled professionals is expected to impede market growth. Amniotic membrane-based products are most commonly used in the treatment of various areas, such as venous, pressure, and diabetic foot ulcers, ophthalmology, surgeries, and also in the management of chronic wounds. Moreover, with increasing research in the field of stem cell research and regenerative medicine, various research and academic institutes are engaged in a study to facilitate the usage of these products for other applications.

Amniotic Membrane Market Report Highlights:

• The cryopreserved amniotic membrane segment held the largest revenue share of more than 50.0% in 2023 owing to the high effectivity and preservation of histological and biological properties in these membranes
• The surgical wounds segment accounted for the maximum revenue share of 36.7% in 2023 due to the increased volume of surgical procedures and wide product usage in surgical applications
• Specialty clinics are anticipated to gain the highest market share by 2030 due to the increasing number of cosmetic and reconstructive surgeries being performed globally
• North America dominated the market in 2023 with a revenue share of 31.7% owing to the existence of a large number of major players and the high incidence of chronic and infectious diseases
• Asia Pacific is expected to grow at the fastest CAGR of 14.5% during the forecast period due to the high population coupled with the rising chronic diseases and burn incidences

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.1. Segment Definitions
  • 1.1.1. Product
  • 1.1.2. Application
  • 1.1.3. End Use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecasts timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Amniotic Membrane Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising research on stem cell biology and regenerative medicine
    • 3.2.1.2. Increasing awareness towards benefits offered by amniotic membrane
    • 3.2.1.3. Rise in the number of accident and trauma cases
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of skilled professionals
    • 3.2.2.2. Lack of standardized guidelines
• 3.3. Amniotic Membrane Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Amniotic Membrane Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Amniotic Membrane Market: Product Movement Analysis
• 4.3. Amniotic Membrane Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Cryopreserved Amniotic Membrane
  • 4.5.1. Cryopreserved Amniotic Membrane Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Dehydrated Amniotic Membrane
  • 4.6.1. Dehydrated Amniotic Membrane Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Amniotic Membrane Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Amniotic Membrane Market: Application Movement Analysis
• 5.3. Amniotic Membrane Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Surgical Wounds
  • 5.5.1. Surgical Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Ophthalmology
  • 5.6.1. Ophthalmology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Amniotic Membrane Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Amniotic Membrane Market: End Use Movement Analysis
• 6.3. Amniotic Membrane Market by End Use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Ambulatory Surgical Centers
  • 6.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Specialty Clinics
  • 6.7.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Research Institutes and Academic Institutes
  • 6.8.1. Research Institutes and Academic Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Amniotic Membrane Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Amniotic Membrane Market movement analysis
• 7.3. Amniotic Membrane Market: Regional Estimates & Trend Analysis by Product, Application & End Use
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. UK Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Germany Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. France Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. Italy Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Spain Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Denmark
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Denmark Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Competitive Scenario
    • 7.6.8.3. Regulatory Framework
    • 7.6.8.4. Reimbursement scenario
    • 7.6.8.5. Sweden Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.9. Norway
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Competitive Scenario
    • 7.6.9.3. Regulatory Framework
    • 7.6.9.4. Reimbursement scenario
    • 7.6.9.5. Norway Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Asia Pacific Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Japan
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Japan Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. China
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. China Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. India
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. India Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. South Korea Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.6. Australia
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Competitive Scenario
    • 7.7.6.3. Regulatory Framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Australia Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.7. Thailand
    • 7.7.7.1. Key Country Dynamics
    • 7.7.7.2. Competitive Scenario
    • 7.7.7.3. Regulatory Framework
    • 7.7.7.4. Reimbursement scenario
    • 7.7.7.5. Thailand Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Latin America Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. Brazil
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. Brazil Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Argentina Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.9. Middle East & Africa
  • 7.9.1. Middle East & Africa Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.2. South Africa
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Competitive Scenario
    • 7.9.2.3. Regulatory Framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. South Africa Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.3. Saudi Arabia
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Competitive Scenario
    • 7.9.3.3. Regulatory Framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. Saudi Arabia Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.4. UAE
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Competitive Scenario
    • 7.9.4.3. Regulatory Framework
    • 7.9.4.4. Reimbursement scenario
    • 7.9.4.5. UAE Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.5. Kuwait
    • 7.9.5.1. Key Country Dynamics
    • 7.9.5.2. Competitive Scenario
    • 7.9.5.3. Regulatory Framework
    • 7.9.5.4. Reimbursement scenario
    • 7.9.5.5. Kuwait Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Alliqua BioMedical Inc.
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Amnio Technology, LLC.
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Applied Biologics LLC
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Human Regenerative Technologies, LLC
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. DermaSciences
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Katena Products, Inc.
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. MiMedx Group Inc.
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Skye Biologics, Inc.
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Amniox Medical Inc.
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Integra LifeSciences
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives